Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

pfizerworld

Pfizer abandons cancer trial

May 22, 2013
Research and Development, Sales and Marketing Cancer, Inotuzumab ozogamicin, Pfizer, oncology

Pfizer’s oncology pipeline has suffered a blow with the company abandoning a Phase III study of one of its investigational …

News
Amgen image

Amgen and Zhejiang sign cancer deal

May 14, 2013
Sales and Marketing Amgen, Cancer, Zhejiang

Amgen has signed a joint venture deal with Chinese firm Zhejiang Beta Pharma to commercialise oncology drug Vectibix. The companies …

News
Boehringer image

Boehringer and OBT in cancer tie-up

May 2, 2013
Research and Development, Sales and Marketing Boehringer, Cancer, OBT

Boehringer Ingelheim and UK biotech firm Oxford BioTherapeutics (OBT) have signed a deal to discover novel antibody targets in cancer. …

News

£50m oncology fund pays out

April 24, 2013
Research and Development, Sales and Marketing Cancer, ICR, MPS1

The Institute of Cancer Research (ICR) in London has become the first recipient of money from a £50 million fund …

News
tamiflu

Cancer drugs boost Roche

April 12, 2013
Sales and Marketing Cancer, Q1, Roche

Roche saw overall sales rise 6% year-on-year in the first three months of this year on the back of a …

News

$33m prizes for research

February 22, 2013
Research and Development Breakthrough Prize in Life Sciences, Cancer, Facebook, google

Life science research has a new multi-million dollar prize from the founders of Facebook and Google.The not-for-profit Breakthrough Prize in …

News

VBP negotiations ‘opened up’

February 19, 2013
Sales and Marketing ABPI, Cancer, EMIG, NHS, VBP

Patient views will for the first time be heard in negotiations between the Department of Health and ABPI about Value-Based …

News
lilly image

Survey shock for pharma

February 4, 2013
Medical Communications, Research and Development, Sales and Marketing Cancer, PACE, lilly, pharma, research

A survey released to tie in with today’s World Cancer Day finds that most people feel pharma companies see cancers …

News

Boehringer in oncology tie-up

January 16, 2013
Research and Development, Sales and Marketing Boehringer, Cancer, horizon, x-man

Boehringer Ingelheim has entered a five-year tie-up with a UK biotech company which specialises in helping research into personalised medicines. …

News
Tamoxifen image

NICE consults on tamoxifen

January 15, 2013
Sales and Marketing Cancer, Evista, NICE, lilly, tamoxifen

Patient groups have welcomed NICE’s new draft guideline recommending the use of preventive treatments in women who have a family …

News
Eisai image

Eisai cancer drug fails

January 14, 2013
Research and Development, Sales and Marketing Cancer, Eisai, Morphotek, farletuzumab

Eisai’s investigational oncology treatment farletuzumab has failed to reach its primary endpoint in a late-stage trial. Farletuzumab (MORAb-003) did not …

News

Merck KGaA pipeline hit

December 21, 2012
Research and Development, Sales and Marketing Cancer, Merck KGaA, NSCLC, pipeline

Merck KGaA’s pipeline has been dented by the ‘disappointing’ late-stage failure of Stimuvax in a programme with non-small cell lung …

News

Perjeta recommended in EU

December 18, 2012
Sales and Marketing CHMP, Cancer, Perjeta, Roche

Roche’s breast cancer treatment Perjeta has been given the thumbs up by the CHMP, paving the way for its approval …

News
Roche image

Swiss Re helps Roche open up China’s oncology market

December 17, 2012
Sales and Marketing Cancer, China, Roche, Swiss re, oncology

Roche and reinsurance firm Swiss Re have teamed up to find an innovative way into China’s healthcare market. For the …

News
Perjec

Perjeta reduces risk of death

December 11, 2012
Sales and Marketing Cancer, Perjeta, Roche

Roche’s cancer drug Perjeta helps reduce the risk of death by 34% in patients with HER2-positive metastatic breast cancer (mBC), …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026